KDR PHARMA PRIVATE LIMITED
KDR PHARMA PRIVATE LIMITED is a ANDHRA PRADESH based PRIVATE LIMITED company, Registered at dated 21-NOV-2014 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of KDR PHARMA PRIVATE LIMITED is U24232TG2014PTC096503 and registration number is 096503.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies HYDERABAD India. Authorized share capital of KDR PHARMA PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on 0 and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 0.
KDR PHARMA PRIVATE LIMITED has 2 directors RAJKIRAN MIRYALKAR, GHANSHYAM MIRYALKAR,
The registered Email address of KDR PHARMA PRIVATE LIMITED is miryalkar_rajkiran@yahoo.com and its registered address is H.NO: 12-69, K.R. NAGAR, DILSUKHNAGAR HYDERABAD TELANGANA INDIA 500060 ANDHRA PRADESH ANDHRA PRADESH india 500060.
The current status of KDR PHARMA PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
KDR PHARMA PRIVATE LIMITED
HYDERABAD
ACTIVE
METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING
U24232TG2014PTC096503
21 NOV 2014
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
500060
INDIA
H.NO: 12-69, K.R. NAGAR, DILSUKHNAGAR HYDERABAD TELANGANA INDIA 500060
miryalkar_rajkiran@yahoo.com
DIRECTOR DETAILS
| DIN | Director Name | Designation | Appointment Date |
|---|---|---|---|
| 07014701 | RAJKIRAN MIRYALKAR | Director | 21/11/2014 |
| 07014749 | GHANSHYAM MIRYALKAR | Director | 21/11/2014 |
Details Updated by Companies
Quick Links
- All Registered company of ANDHRA PRADESH
- Company Registered in ANDHRA PRADESH
- All Registered company of HYDERABAD in ANDHRA PRADESH
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.